Otsuka Holdings Co (STU:OS1) Long-Term Debt: €477 Mil (As of Mar. 2026)


STU:OS1 Otsuka Holdings Co Ltd STU:OS1
86 GF Score
Price €60.50
GF Value €45.14
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Otsuka Holdings Co Long-Term Debt?

Otsuka Holdings Co STU:OS1 -0.82% 86 Long-Term Debt is €477 Mil as of Mar. 2026. GuruFocus rates STU:OS1 with a GF Score™ of 86/100 and a GF Value™ of €45.14 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Otsuka Holdings Co's Long-Term Debt for the quarter that ended in Mar. 2026 was €477 Mil.

Otsuka Holdings Co's quarterly Long-Term Debt declined from Sep. 2025 (€497 Mil) to Dec. 2025 (€481 Mil) and declined from Dec. 2025 (€481 Mil) to Mar. 2026 (€477 Mil).

Otsuka Holdings Co's annual Long-Term Debt increased from Dec. 2023 (€441 Mil) to Dec. 2024 (€542 Mil) but then declined from Dec. 2024 (€542 Mil) to Dec. 2025 (€481 Mil).

Otsuka Holdings Co  (STU:OS1) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Otsuka Holdings Co Long-Term Debt Related Terms

Otsuka Holdings Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Otsuka Holdings Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otsuka Holdings Co Long-Term Debt Chart

Otsuka Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 798.87 656.14 440.73 541.87 481.22

Otsuka Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 352.89 519.34 497.37 481.22 477.33
STU:OS1
86GF Score
Otsuka Holdings Co Ltd STU:OS1
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €477 Mil mean?
Otsuka Holdings Co (STU:OS1) has a Long-Term Debt of €477 Mil as of Mar. 2026.
Is Otsuka Holdings Co's Long-Term Debt too high?
Otsuka Holdings Co's current Long-Term Debt is €477 Mil. Overall, Otsuka Holdings Co has a GF Score™ of 86/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's Long-Term Debt compare to LLY and JNJ?
Otsuka Holdings Co's Long-Term Debt of €477 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Otsuka Holdings Co's current Long-Term Debt is €477 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Otsuka Holdings Co (STU:OS1) is currently considered Significantly Overvalued. The stock's GF Value™ is €45.14, compared to a current price of €60.50 — trading 34% above its estimated fair value. The current Long-Term Debt is €477 Mil. Otsuka Holdings Co's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Otsuka Holdings Co (STU:OS1), the current Long-Term Debt is €477 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Otsuka Holdings Co (STU:OS1) Overvalued in 2026?

Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued. The current stock price of €60.50 is trading 34% above its estimated GF Value™ of €45.14. GuruFocus considers Otsuka Holdings Co to be Significantly Overvalued.

Key valuation signals for STU:OS1:

  • Long-Term Debt: €477 Mil
  • GF Value™: €45.14 vs. price of €60.50 (34% above fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the STU:OS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Otsuka Holdings Co Business Description

Address 2-16-4 Konan, Shinagawa Grand Central Tower, Minato-ku, Tokyo, JPN, 108-8241
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
86GF Score

Get the complete analysis for STU:OS1

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€60.50
Price
€45.14
GF Value